REFERÊNCIAS
94
Grossman RG, Meagher JN, Young W, Fischer B, Clifton GL, Hunt WE, Rifkinson
N. Methylprednisolone and neurological function 1 year after spinal cord injury–
Results of the national acute spinal cord injury study. J Neurosurg. 1985;63:704-13.
Bracken MB, Shepard MJ, Collins WF, Holford TR, Baskin DS, Eisenberg HM,
Flamm E, Leo-Summers L, Maroon JC, Marshall LF, Perot PL, Piepmeier J, Sonntag
VKH, Wagner FC Jr, Wilberger LL, Winn HR, Young W. Methylprednisolone or
naloxene treatment after acute spinal cord injury: 1- year follow-up data. Results of
the second National Spinal Cord Injury Study. J Neurosurg. 1992;76:23-31.
Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone
administration on recovery of segmental and long-tract neurological function in
NASCIS 2. J Neurosurg. 1993;79:500-7.
Bracken MB, Sheopard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M,
Fehlings M, Herr DL, Hitchon PW, Marshall LF, Njockels RP, Pascale V, Perot PL,
Piepmeier J, Sonntag VKH, Wagner F, Wilberger JE, Winn HR, Young W.
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48
hours in the treatment of acute spinal cord injury. Results of the third national acute
spinal cord injury randomized controlled trial. JAMA. 1997;277:P. 1597-604.
Bracken MB, Sheopard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M,
Fehlings MG, Herr DL, Hitchonj PW, Marshall LF, Nockels RP, Pascale V, Perot
PL, Piepmeier J, Sonntag VKH, Wagner F, Wilberger JE, Winn HR, Young W.
Methylprednisolone or tirilazad mesylate administration after acute spinal cord